Dr. Rennard receives Pfizer Visiting Professorship Award









picture disc.


Jeff Anderson of Pfizer, Inc., presents the 2006 Pfizer Visiting Professorship in Pulmonology award to UNMC’s Stephen Rennard, M.D.

Stephen Rennard, M.D., one of the world’s leading experts in chronic obstructive pulmonary disease, was one of 10 physicians selected for the 2006 Pfizer Visiting Professorship in Pulmonology Award.

Dr. Rennard, Larson Professor of Medicine in the UNMC Pulmonary and Critical Care Section, will travel in March to the University of Texas Medical Branch at Galveston where he will be a visiting professor.

Over a two-day visit, Dr. Rennard will conduct four or five lectures and meet with faculty and practicing physicians from the Houston-Galveston area. He will discuss the science and management of chronic obstructive pulmonary disease and career development in pulmonary medicine.

“Dr Rennard has uncommon breadth of expertise, both in pulmonary disorders and asthma,” said William Calhoun, M.D., vice chairman for planning research and development for the department of internal medicine at the University of Texas Medical Branch at Galveston. “He is an ideal candidate for this award. He’s a superb academic pulmonologist, whose depth and breadth of expertise has been recognized by his peers.”

The purpose of the program is to increase opportunities for scientific exchange and education at medical schools, teaching hospitals and other organizations. About 80 visiting professorships are awarded annually in various areas of medicine. The recipients are selected by independent academic advisory boards made up of top scholars.

Dr. Rennard said he is flattered to receive the award.

“The University of Texas Medical Branch at Galveston recently combined allergy, pulmonary, immunology, critical care and sleep medicine into one division. Their goal is to develop a nationally-recognized, top 10 program over the next five years,” Dr. Rennard said. “Part of my role will be to assess their plans for this ambitious program.”

The visiting professorships are part of Pfizer’s Medical and Academic Partnerships (MAP) grant program. Since 1984, the grants have created and supported more than 900 educational opportunities, demonstrating Pfizer’s commitment to health care scholarship and enhancing education at institutions and organizations across the United States.